Basic Information
| LncRNA/CircRNA Name | uc.283 |
| Synonyms | NA |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | glioma |
| ICD-0-3 | NA |
| Methods | Microarray, qPCR etc. |
| Sample | glioma tissues |
| Expression Pattern | up-regulated |
| Function Description | Among the normal tissues, the uc.283 lncRNA was highly specific for pluripotent stem cells. Intriguingly, the uc.283-plus lncRNA was highly expressed in some solid cancers, particularly in one of the most untreatable types, glioma.uc.283-plus lncRNA might have a role in pluripotency of stem cells and in the biology of glioma. |
| Pubmed ID | 25352916 |
| Year | 2014 |
| Title | A large scale expression study associates uc.283-plus lncRNA with pluripotent stem cells and human glioma. |
External Links
| Links for uc.283 | GenBank HGNC NONCODE |
| Links for glioma | OMIM COSMIC |